Regulatory

​KinetoChem possesses three U.S. Drug Enforcement Administration (DEA) licenses for Schedule 1 controlled substances:

KinetoChem develops processes and procedures to meet FDA and cGMP guidelines.

We have expertise in small molecule synthesis and large-scale liquid chromatography to provide high purity compounds.

KinetoChem’s services provide the ability to move API products from inception to full cGMP manufacturing.